Search

everythinglearnresearchcommunity

for

Search:↓

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

The KRTAP7-1 gene is very similar across different cattle and yak breeds and likely plays a role in hair strength and shape.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Certain genetic variations in camels affect hair coarseness.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Androgen receptors help prostate cancer cells grow and resist drugs.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Leflunomide is more likely to help treat alopecia areata than cause it.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

EDA2R gene linked to hair loss.